[HTML][HTML] Socioeconomic status and the 25× 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1· 7 million men and …
Background In 2011, WHO member states signed up to the 25× 25 initiative, a plan to cut
mortality due to non-communicable diseases by 25% by 2025. However, socioeconomic …
mortality due to non-communicable diseases by 25% by 2025. However, socioeconomic …
The relationship between different dimensions of alcohol use and the burden of disease—an update
Background and aims Alcohol use is a major contributor to injuries, mortality and the burden
of disease. This review updates knowledge on risk relations between dimensions of alcohol …
of disease. This review updates knowledge on risk relations between dimensions of alcohol …
Transboundary health impacts of transported global air pollution and international trade
Millions of people die every year from diseases caused by exposure to outdoor air
pollution,,,,. Some studies have estimated premature mortality related to local sources of air …
pollution,,,,. Some studies have estimated premature mortality related to local sources of air …
7ª Diretriz brasileira de hipertensão arterial: apresentação
MVB Malachias - Arquivos brasileiros de cardiologia, 2016 - SciELO Brasil
A avaliação inicial de um paciente com hipertensão arterial sistêmica (HAS) inclui a
confirmação do diagnóstico, a suspeição e a identificação de causa secundária, além da …
confirmação do diagnóstico, a suspeição e a identificação de causa secundária, além da …
[HTML][HTML] Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990 …
GBD 2016 Risk Factors Collaborators - Lancet (London, England …, 2017 - ncbi.nlm.nih.gov
Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD
2016) provides a comprehensive assessment of risk factor exposure and attributable burden …
2016) provides a comprehensive assessment of risk factor exposure and attributable burden …
Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart …
RM Carey, PK Whelton… - Annals of internal …, 2018 - acpjournals.org
Description: In November 2017, the American College of Cardiology (ACC) and the
American Heart Association (AHA) released a clinical practice guideline for the prevention …
American Heart Association (AHA) released a clinical practice guideline for the prevention …
[HTML][HTML] Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis
S Popova, S Lange, C Probst, G Gmel… - The Lancet Global …, 2017 - thelancet.com
Background Alcohol use during pregnancy is the direct cause of fetal alcohol syndrome
(FAS). We aimed to estimate the prevalence of alcohol use during pregnancy and FAS in the …
(FAS). We aimed to estimate the prevalence of alcohol use during pregnancy and FAS in the …
Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States
Importance In the United States, national associations of individual dietary factors with
specific cardiometabolic diseases are not well established. Objective To estimate …
specific cardiometabolic diseases are not well established. Objective To estimate …
[PDF][PDF] Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis
World Health Organization - 2017 - apps.who.int
Инфекционные заболевания во всем мире входят в десятку самых распространенных
причин смертности и являются ведущим фактором, обусловливающим годы жизни …
причин смертности и являются ведущим фактором, обусловливающим годы жизни …
[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …